November 29 Quad-Regulatory Boards Policy for Prescribing Opioids

November 21, 2016

The Colorado healthcare licensing boards in DORA’s Division of Professions and Occupations are hosting a community meeting from 10:00 a.m. to 12:00 noon on Nov. 29, 2016 at 1560 Broadway, Suite 1900.  This event will provide an opportunity for representatives from the Medical, Dental, Nursing, and Pharmacy Boards to hear from the community on the impact of the Colorado Policy for Prescribing and Dispensing Opioids and related issues.

Following the Governor’s 2013 landmark plan, the Colorado Plan to Reduce Prescription Drug Abuse, DORA’s healthcare licensing boards promulgated the above policy to provide guidance to practitioners in safely prescribing and dispensing addictive painkillers.  It was the first such joint policy in the nation, where practitioners from different disciplines agreed to a common set of standards to compassionately treat pain, while reducing the problems resulting from misuse and abuse of prescription opioids.  The Boards are now evaluating the effectiveness and usefulness of the policy to determine if any changes are needed.

The Boards for the community meeting will partner with the Colorado Consortium for Prescription Drug Abuse Prevention to raise maximum awareness about the event. Colorado patients and the community at large will participate, including healthcare professionals, patient family members, behavioral health specialists, substance abuse treatment providers, and the general public at large.  Media and local elected officials will be invited to attend.

The Boards want and need the public’s input to understand the needs of Coloradans and the impact of the policy in order to craft right-touch guidelines that serve the dual purposes of treating the individual patient and the public health.

Date and Time:

November 29, 2016

10:00 a.m. to 12:00 noon

Location:

1560 Broadway, Suite 1900 Conference Room

Denver, CO 80202

We hope you will be able to attend.

If you have any questions or need additional information, please contact me at [email protected] or 303-894-7434.